Ceapro Inc. (CVE:CZO – Get Free Report)’s stock price dropped 11.8% during mid-day trading on Monday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares were traded during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The company has a quick ratio of 18.88, a current ratio of 7.10 and a debt-to-equity ratio of 8.28. The stock’s 50 day moving average price is C$0.22 and its two-hundred day moving average price is C$0.23. The firm has a market capitalization of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Articles
- Five stocks we like better than Ceapro
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- A U.S. “birthright” claim worth trillions – activated quietly
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
